Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Two Investigational Pneumococcal Vaccines in Healthy Adults
This study has been completed.
Study NCT01444339   Information provided by Sanofi

First Received on September 28, 2011.   Last Updated on September 29, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pneumococcal Infections
Streptococcus Pneumoniae Infections
Pneumococcal Pneumonia
Additional conditions recognized in this trial
Pneumonia
Pneumonia, Pneumococcal
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Lung Diseases
Pneumonia, Bacterial
Respiratory Tract Diseases
Respiratory Tract Infections
Streptococcal Infections
Interventions listed in this trial
Pneumococcal Vaccine Formulation 1
Pneumococcal Vaccine Formulation 2
Pneumococcal Vaccine Formulation 3
Pneumococcal Vaccine Formulation 4
Pneumococcal Vaccine Formulation 5
Placebo
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services